Pacific Biosciences Of California (PACB) Raw Materials (2011 - 2026)

Pacific Biosciences Of California has reported Raw Materials for 16 years, with the latest figure at $34.7 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 21.9% year-over-year to $34.7 million; the trailing twelve-month figure through Mar 2026 stood at $34.7 million (down 21.9% YoY), and the FY2025 full-year result was $38.6 million, down 14.65% from the prior year.
• Raw Materials for Q1 2026 stood at $34.7 million, down from $38.6 million in the prior quarter.
• The five-year high for Raw Materials was $46.0 million in Q2 2025, with the low at $11.5 million in Q1 2022.
• Average Raw Materials over 5 years is $30.2 million, with a median of $29.9 million recorded in 2024.
• Year-over-year, Raw Materials jumped 202.0% in 2022 and declined 21.9% in 2026.
• Tracing PACB's Raw Materials over 5 years: stood at $24.1 million in 2022, then soared by 34.36% to $32.4 million in 2023, then jumped by 39.58% to $45.3 million in 2024, then retreated by 14.65% to $38.6 million in 2025, then dropped by 10.1% to $34.7 million in 2026.
• The last three Raw Materials figures came in at $34.7 million (Q1 2026), $38.6 million (Q4 2025), and $41.8 million (Q3 2025), per Business Quant data.

Peer Comparison